Cargando…
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
Autor principal: | Moghimi, S. Moein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862013/ https://www.ncbi.nlm.nih.gov/pubmed/33571463 http://dx.doi.org/10.1016/j.ymthe.2021.01.030 |
Ejemplares similares
-
Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
por: Somiya, Masaharu, et al.
Publicado: (2021) -
COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
Publicado: (2021) -
COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group
por: Kim, Mi-Ae, et al.
Publicado: (2021) -
Could amantadine interfere with COVID-19 vaccines based on the LNP-mRNA platform?
por: Fedorowski, Jaroslaw J.
Publicado: (2021) -
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines
por: Murphy, Kevin R., et al.
Publicado: (2021)